1236 Assessment of pharmacodynamic effect in a Phase I study of NPI-2358, an IV administered vascular disruptive agent, using dynamic contrast-enhanced MRI

2009 ◽  
Vol 7 (2) ◽  
pp. 131
Author(s):  
E. Ashton ◽  
K. Lloyd ◽  
M. Spear
2016 ◽  
Vol 207 (5) ◽  
pp. 1022-1030 ◽  
Author(s):  
Eli Eikefjord ◽  
Erling Andersen ◽  
Erlend Hodneland ◽  
Einar Svarstad ◽  
Arvid Lundervold ◽  
...  

2021 ◽  
Author(s):  
Lisanne P. W. Canjels ◽  
Jacobus F. A. Jansen ◽  
Marieke Kerkhof ◽  
Robert‐Jan Alers ◽  
Benedikt A. Poser ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document